Literature DB >> 3662604

Contrasting disease patterns in psoriasis and atopic dermatitis.

E Christophers1, T Henseler.   

Abstract

In this report we investigate the simultaneous occurrence of psoriasis and atopic dermatitis (AD) as well as the association with infectious skin diseases. Among 29,159 patients hospitalized between 1953 and 1983, 8.5% (2,467 patients) were treated for psoriasis, while 1.6% (470 patients) were hospitalized for AD treatment. On the basis of incidence rates for both diseases, 36 patients (0.14%) with both psoriasis and AD were expected to be seen. However, the two conditions were simultaneously present in 2 patients only. Approximately 30% of the AD patients were suffering from either bacterial or viral infection, while this complication occurred in 6.7% of psoriatics. In addition, among 48 patients hospitalized for eczema herpeticatum 39 were atopics and none was psoriatic. The data demonstrate that the occurrence of psoriasis and AD in one and the same patient is quite rare and this may be related to conflicting immune defense patterns. Thus, increased sensitization against foreign protein together with high susceptibility to cutaneous infection present in AD is in contrast to high phagocyte responsiveness in psoriasis, where concurrent infections are rare.

Entities:  

Mesh:

Year:  1987        PMID: 3662604     DOI: 10.1007/bf00585919

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  19 in total

Review 1.  Cellular abnormalities in patients with elevated serum IgE levels.

Authors:  R S Geha; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1986-11       Impact factor: 10.793

Review 2.  Atopic dermatitis.

Authors:  J M Hanifin
Journal:  J Allergy Clin Immunol       Date:  1984-02       Impact factor: 10.793

3.  Leucocyte activation initiated by IgE-dependent mechanisms in relation to helminthic parasitic disease and clinical models of asthma.

Authors:  A B Kay; R Moqbel; S R Durham; A J MacDonald; G M Walsh; R J Shaw; O Cromwell; J Mackay
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

4.  Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.

Authors:  G Kawohl; B Szperalski; J M Schröder; E Christophers
Journal:  Br J Dermatol       Date:  1980-11       Impact factor: 9.302

5.  Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis.

Authors:  G S Lazarus; F J Yost; C A Thomas
Journal:  Science       Date:  1977-12-16       Impact factor: 47.728

6.  Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris.

Authors:  T Henseler; E Christophers
Journal:  J Am Acad Dermatol       Date:  1985-09       Impact factor: 11.527

7.  Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E, and defective neutrophil chemotaxis.

Authors:  H R Hill; R D Estensen; N A Hogan; P G Quie
Journal:  J Lab Clin Med       Date:  1976-11

8.  Hyperimmunoglobulin-E-associated recurrent infection syndrome accompanied by chemotactic inhibition of polymorphonuclear leukocytes and monocytes.

Authors:  S Chikazawa; H Nunoi; F Endo; I Matsuda; M Honda
Journal:  Pediatr Res       Date:  1984-04       Impact factor: 3.756

9.  Increased granulocyte adherence in psoriasis and psoriatic arthritis.

Authors:  J B Sedgwick; P R Bergstresser; E R Hurd
Journal:  J Invest Dermatol       Date:  1980-02       Impact factor: 8.551

10.  Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.

Authors:  W C Preissner; J M Schröder; E Christophers
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

View more
  30 in total

Review 1.  What is the 'true' function of skin?

Authors:  C M Chuong; B J Nickoloff; P M Elias; L A Goldsmith; E Macher; P A Maderson; J P Sundberg; H Tagami; P M Plonka; K Thestrup-Pederson; B A Bernard; J M Schröder; P Dotto; C M Chang; M L Williams; K R Feingold; L E King; A M Kligman; J L Rees; E Christophers
Journal:  Exp Dermatol       Date:  2002-04       Impact factor: 3.960

2.  Activation of the complement system generates antibacterial peptides.

Authors:  Emma Andersson Nordahl; Victoria Rydengård; Patrik Nyberg; D Patric Nitsche; Matthias Mörgelin; Martin Malmsten; Lars Björck; Artur Schmidtchen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-18       Impact factor: 11.205

3.  Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens.

Authors:  Marissa H Braff; Mohamed Zaiou; Joshua Fierer; Victor Nizet; Richard L Gallo
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 4.  Host defense peptides in wound healing.

Authors:  Lars Steinstraesser; Till Koehler; Frank Jacobsen; Adrien Daigeler; Ole Goertz; Stefan Langer; Marco Kesting; Hans Steinau; Elof Eriksson; Tobias Hirsch
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 5.  Current insights into the role of human β-defensins in atopic dermatitis.

Authors:  P Chieosilapatham; H Ogawa; F Niyonsaba
Journal:  Clin Exp Immunol       Date:  2017-08-04       Impact factor: 4.330

6.  Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.

Authors:  Emma Guttman-Yassky; Michelle A Lowes; Judilyn Fuentes-Duculan; Lisa C Zaba; Irma Cardinale; Kristine E Nograles; Artemis Khatcherian; Inna Novitskaya; John A Carucci; Reuven Bergman; James G Krueger
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 7.  Role of bacterial pathogens in atopic dermatitis.

Authors:  Yu-Tsan Lin; Chen-Ti Wang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

8.  Pulsed-field gel electrophoresis of Staphylococcus aureus isolates from atopic patients revealing presence of similar strains in isolates from children and their parents.

Authors:  Sonja Bonness; Christiane Szekat; Natalija Novak; Gabriele Bierbaum
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

Review 9.  Innate immunity and antimicrobial defense systems in psoriasis.

Authors:  Amanda S Büchau; Richard L Gallo
Journal:  Clin Dermatol       Date:  2007 Nov-Dec       Impact factor: 3.541

Review 10.  National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

Authors:  Alexa B Kimball; Dafna Gladman; Joel M Gelfand; Kenneth Gordon; Elizabeth J Horn; Neil J Korman; Gretchen Korver; Gerald G Krueger; Bruce E Strober; Mark G Lebwohl
Journal:  J Am Acad Dermatol       Date:  2008-03-04       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.